SEC Comment Letter for NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379) (NWBO) — Jan 19, 2006

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)
Date: Jan. 19, 2006 · CIK: 0001072379 · Accession: 0000000000-06-002918

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-33393

Date

January 17, 2006

Author

Jim Atkinson

Form

UPLOAD

Company

NORTHWEST BIOTHERAPEUTICS INC (NWBO) (CIK 0001072379)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 January 17, 2006 Mr. Alton L. Boynton President and Principal Executive Officer Northwest Biotherapeutics, Inc. Canyon Park Building 8 22322 20th Avenue S.E., Suite 150 Bothell, Washington 98021

Re: Northwest Biotherapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2004 Filed April 15, 2005 File No. 000-33393

Dear Mr. Boynton:

We have completed our review of your Form 10-K and have no further comments at this time.

Sincerely,
Jim Atkinson
Accounting Branch Chief
??

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

      January 17, 2006

Mr. Alton L. Boynton
President and Principal Executive Officer
Northwest Biotherapeutics, Inc.
Canyon Park Building 8
22322 20th Avenue S.E., Suite 150
Bothell, Washington 98021

Re:	Northwest Biotherapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2004
	Filed April 15, 2005
	File No. 000-33393

Dear Mr. Boynton:

      We have completed our review of your Form 10-K and have no
further comments at this time.

								Sincerely,

								Jim Atkinson
								Accounting Branch Chief
??

??

??

??

</TEXT>
</DOCUMENT>

SecProbe.io